Page last updated: 2024-10-22

albuterol and Facio-Scapulo-Humeral Dystrophy

albuterol has been researched along with Facio-Scapulo-Humeral Dystrophy in 6 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
"Pain and fatigue are important features in FSHD."6.73Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. ( Bleijenberg, G; Hendriks, JC; Kalkman, JS; Lindeman, E; Padberg, GW; van der Kooi, EL; van Engelen, BG, 2007)
"Albuterol was well tolerated; side effects included cramps, tremors, insomnia, and nervousness."6.70Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. ( Griggs, RC; King, WM; Kissel, JT; McDermott, MP; Mendell, JR; Pandya, S; Tawil, R, 2001)
"Salbutamol (sustained released formulation) administered orally at a daily dose of 16 mg using a periodic dosage regimen (3 wks on, 1 wk off)."2.74Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial. ( Attarian, S; Desnuelle, C; Doppler, V; Eymard, B; Hammouda, EH; Hogrel, JY; Lacomblez, L; LaforĂȘt, P; Ollivier, G; Payan, CA; Pouget, J, 2009)
"Pain and fatigue are important features in FSHD."2.73Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. ( Bleijenberg, G; Hendriks, JC; Kalkman, JS; Lindeman, E; Padberg, GW; van der Kooi, EL; van Engelen, BG, 2007)
"In patients with facioscapulohumeral muscular dystrophy (FSHD) albuterol may exert anabolic effects."2.71Strength training and albuterol in facioscapulohumeral muscular dystrophy. ( Hendriks, JC; Lindeman, E; Padberg, GW; van Asseldonk, RJ; van der Kooi, EL; van der Maarel, SM; Vogels, OJ; Wohlgemuth, M, 2004)
"Albuterol was well tolerated; side effects included cramps, tremors, insomnia, and nervousness."2.70Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. ( Griggs, RC; King, WM; Kissel, JT; McDermott, MP; Mendell, JR; Pandya, S; Tawil, R, 2001)
"Creatine has been used as a muscle performance enhancer by athletes and it might be helpful in muscular dystrophies including facioscapulohumeral muscular dystrophy."2.42Drug treatment for facioscapulohumeral muscular dystrophy. ( Rose, MR; Tawil, R, 2004)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Payan, CA1
Hogrel, JY1
Hammouda, EH1
Lacomblez, L1
Ollivier, G1
Doppler, V1
Eymard, B1
Attarian, S1
Pouget, J1
Desnuelle, C1
LaforĂȘt, P1
Rose, MR1
Tawil, R2
van der Kooi, EL2
Vogels, OJ1
van Asseldonk, RJ1
Lindeman, E2
Hendriks, JC2
Wohlgemuth, M1
van der Maarel, SM1
Padberg, GW2
Kalkman, JS1
van Engelen, BG1
Bleijenberg, G1
Nakagawa, M1
Higuchi, I1
Kissel, JT1
McDermott, MP1
Mendell, JR1
King, WM1
Pandya, S1
Griggs, RC1

Reviews

2 reviews available for albuterol and Facio-Scapulo-Humeral Dystrophy

ArticleYear
Drug treatment for facioscapulohumeral muscular dystrophy.
    The Cochrane database of systematic reviews, 2004, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Creatine; Humans; Muscular Dystrophy, Facioscapulohumeral; Rand

2004
[Facioscapulohumeral muscular dystrophy].
    Ryoikibetsu shokogun shirizu, 2001, Issue:35

    Topics: Adrenergic beta-Agonists; Albuterol; Chromosomes, Human, Pair 4; Deoxyribonucleases, Type II Site-Sp

2001

Trials

4 trials available for albuterol and Facio-Scapulo-Humeral Dystrophy

ArticleYear
Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.
    Archives of physical medicine and rehabilitation, 2009, Volume: 90, Issue:7

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Delayed-Action Preparations;

2009
Strength training and albuterol in facioscapulohumeral muscular dystrophy.
    Neurology, 2004, Aug-24, Volume: 63, Issue:4

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Ankle Joint; Combined Modality Therapy; Delayed-Action P

2004
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.
    Journal of neurology, 2007, Volume: 254, Issue:7

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Combined Modality Therapy; Double-Blind Method; Exercise

2007
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.
    Neurology, 2001, Oct-23, Volume: 57, Issue:8

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Body Mass Index; Double-Blind Method; Female; Hand Stren

2001